Post Profile

Study Uses Genetic Testing to Personalize Treatment for Deadly Blood Cancer

A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). The center is one of seven cancer centers nationwide participating in the Beat AML(r) Master Trial, sponsored by the Leukemia & Lymphoma Society (LLS).
read more


Related Posts

High Dose Chemotherapy Significantly Prolongs Survival For Patients With Acute Myeloid Leukemia

Health : Medical News Today

Preliminary results from a large, randomized clinical trial for patients ages 16 to 60 with previously untreated acute myeloid leukemia (AML), a cancer of the blood and bone marrow, show that patients who received a high dose of a c...

Alternative Option to Intensive Chemotherapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Health : Newswise Medical News

A Yale Cancer Center team has evaluated the use of hypomethylating agents in patients suffering from Acute Myeloid Leukemia (AML) who were resistant to treatment with intensive chemotherapy.

Biofluidica's Liquid Biopsy Allows Replacement of Painful Bone Marrow Biopsy Through a Simple Blood Test for Early Detection of Acute Myeloid Leukemia (AML)

Health : Newswise Medical News

/PRNewswire/ -- BioFluidica, Inc. has released the clinical data for minimal residual disease detection in Acute Myeloid Leukemia (AML) patients using circulating leukemic cells selected from blood. The data was published in the pee...

New cancer treatment strategy discovered for acute myeloid leukemia

Health : EurekAlert: Health

(University of Hawaii Cancer Center) University of Hawai'i Cancer Center researchers discovered a novel therapeutic target and treatment strategy for acute myeloid leukemia (AML), a cancer of the blood and bone marrow that normally ...

Personalized Cancer Vaccine is Associated With Promising Outcomes for Patients with Acute Myeloid Leukemia

Health : Newswise Medical News

A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center (...


Copyright © 2016 Regator, LLC